Rosiglitazone Maleate Patent Expiration
Rosiglitazone Maleate is Used for managing and improving glycemic control in patients with type 2 diabetes mellitus. It was first introduced by Woodward Pharma Services Llc
Rosiglitazone Maleate Patents
Given below is the list of patents protecting Rosiglitazone Maleate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Avandia |
US7358366 (Pediatric) | Thiazolidinedione derivative and its use as antidiabetic |
Oct 19, 2020
(Expired) | Woodward |
| Avandia | US7358366 | Thiazolidinedione derivative and its use as antidiabetic |
Apr 19, 2020
(Expired) | Woodward |
| Avandia |
US6288095 (Pediatric) | Compounds |
Aug 11, 2017
(Expired) | Woodward |
| Avandia | US6288095 | Compounds |
Feb 11, 2017
(Expired) | Woodward |
| Avandia |
US5741803 (Pediatric) | Substituted thiazolidinedionle derivatives |
Oct 21, 2015
(Expired) | Woodward |
| Avandia | US5741803 | Substituted thiazolidinedionle derivatives |
Apr 21, 2015
(Expired) | Woodward |
Rosiglitazone Maleate's Family Patents
Explore Our Curated Drug Screens
Rosiglitazone Maleate Generic API Manufacturers
Several generic applications have been filed for Rosiglitazone Maleate.
Given below is the list of companies who have filed for Rosiglitazone Maleate generic, along with the locations of their manufacturing plants worldwide.
1. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 3 different strengths of generic version for Rosiglitazone Maleate. Given below are the details of the strengths of this generic introduced by Ani Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Jan 25, 2013 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Jan 25, 2013 |
| EQ 8MG BASE | tablet | Discontinued | ORAL | N/A | Jan 25, 2013 |